JCO Article Insights: LEAP-010 Study in Recurrent/Metastatic Head and Neck Cancer
Host Jake New summarizes and offers insights into the JCO article by Licitra et al., "Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study." LINK TO FULL TRANSCRIPT
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Journal of Clinical Oncology (JCO) Podcast
Adjuvant Durvalumab and the Future of Early-Stage NSCLC
Infections in Two Diet Strategies in HSCT and Leukemia Patients
JCO Article Insights: ctDNA in DLBCL - Ready for Prime Time?
The CISTO Study: Radical Cystectomy or Bladder-Sparing Therapy for Recurrent NMIBC
Get summaries like this every morning.
Free AI-powered recaps of Journal of Clinical Oncology (JCO) Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.